Zdravka Medarova

CIK 1855758 · View on SEC EDGAR ↗

Insider

First SEC filing: July 8, 2021 · Latest: July 8, 2021

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 2 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Dec. 12, 2022 RNAZ A 60,000 60,000 Direct Acquired (price as of 2026-08-21)
Feb. 1, 2022 RNAZ A 33,000 33,000 Direct Acquired (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Dec. 12, 2022 RNAZ Stock Option (Right to Buy) Common Stock (60,000) $0.56 Dec. 11, 2027 60,000 Acquired
Feb. 1, 2022 RNAZ Stock Option (Right to Buy) Common Stock (33,000) $2.45 Jan. 31, 2027 33,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
July 8, 2021 RNAZ Common Stock 1,552,785 Direct
July 8, 2021 RNAZ Stock Option (Right to Buy)→ Common Stock (121,311) 121,311 Direct